LS-P-COASTAL

LS-P-COASTAL: Phase I study of inhibitor of SIRPa-CD47 axis with trastuzumab and deruxtecan for HER2+ solid tumors and cohort for HER2 low breast cancer
Status:

Open

Contact:

Stephanie Graff, MD
sgraff1@brownhealth.org